Cargando…

Ratiometric Activatable Cell-Penetrating Peptides Provide Rapid In Vivo Readout of Thrombin Activation**

Detalles Bibliográficos
Autores principales:	Whitney, Michael, Savariar, Elamprakash N, Friedman, Beth, Levin, Rachel A, Crisp, Jessica L, Glasgow, Heather L, Lefkowitz, Roy, Adams, Stephen R, Steinbach, Paul, Nashi, Nadia, Nguyen, Quyen T, Tsien, Roger Y
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	WILEY-VCH Verlag 2013
Materias:	Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694763/ https://www.ncbi.nlm.nih.gov/pubmed/23080482 http://dx.doi.org/10.1002/anie.201205721

Ejemplares similares

In Vivo Targeting of Hydrogen Peroxide by Activatable Cell-Penetrating Peptides
por: Weinstain, Roy, et al.
Publicado: (2013)

Sensitive in vivo Visualization of Breast Cancer Using Ratiometric Protease-activatable Fluorescent Imaging Agent, AVB-620
por: Miampamba, Marcel, et al.
Publicado: (2017)

Impact of MMP-2 and MMP-9 enzyme activity on wound healing, tumor growth and RACPP cleavage
por: Hingorani, Dina V., et al.
Publicado: (2018)

Anti-tubulin drugs conjugated to anti-ErbB antibodies selectively radiosensitize
por: Adams, Stephen R., et al.
Publicado: (2016)

Improved Facial Nerve Identification with Novel Fluorescently Labeled Probe
por: Wu, Amy P, et al.
Publicado: (2011)

Tumor Detection at 3 Tesla with an Activatable Cell Penetrating Peptide Dendrimer (ACPPD-Gd), a T1 Magnetic Resonance (MR) Molecular Imaging Agent
por: Malone, Christopher D., et al.
Publicado: (2015)

Thrombin Activatable Fibrinolysis Inhibitor (TAFI): An Updated Narrative Review
por: Sillen, Machteld, et al.
Publicado: (2021)

Biochemical characterization of bovine plasma thrombin-activatable fibrinolysis inhibitor (TAFI)
por: Valnickova, Zuzana, et al.
Publicado: (2009)

Early detection of thrombin activity in neuroinflammatory disease
por: Davalos, Dimitrios, et al.
Publicado: (2014)

Elevated levels of activated and inactivated thrombin-activatable fibrinolysis inhibitor in patients with sepsis
por: Park, Rojin, et al.
Publicado: (2010)

Increased thrombin activatable fibrinolysis inhibitor activity is associated with hypofibrinolysis in dogs with sepsis
por: Sotos, Katherine E., et al.
Publicado: (2023)

Activatable cell-penetrating peptides: 15 years of research
por: de Jong, Heleen, et al.
Publicado: (2020)

Fluorescently Labeled Peptide Increases Identification of Degenerated Facial Nerve Branches during Surgery and Improves Functional Outcome
por: Hussain, Timon, et al.
Publicado: (2015)

Thrombin-activatable fibrinolysis inhibitor and organ dysfunction in disseminated intravascular coagulation associated with sepsis
por: Hayakawa, M, et al.
Publicado: (2011)

Data supporting the structural and functional characterization of Thrombin‐Activatable Fibrinolysis Inhibitor in breast cancer
por: Fawzy, Manal S., et al.
Publicado: (2015)

Thrombin-Activatable Fibrinolysis Inhibitor Polymorphisms and Cerebral Venous Thrombosis in Mexican Mestizo Patients
por: Arauz, Antonio, et al.
Publicado: (2018)

Plasma thrombin-activatable fibrinolysis inhibitor (TAFI) antigen levels in acromegaly patients in remission
por: ERDOĞAN, Mehmet, et al.
Publicado: (2019)

Nerve-targeted probes for fluorescence-guided intraoperative imaging
por: Hingorani, Dina V, et al.
Publicado: (2018)

Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) Deficient Mice Are Susceptible to Intracerebral Thrombosis and Ischemic Stroke
por: Kraft, Peter, et al.
Publicado: (2010)

Is there any role of thrombin activatable fibrinolysis inhibitor in the development of a hypercoagulable state in gastric cancer
por: Eser, Mehmet, et al.
Publicado: (2012)

Generation of hydroxyl radical-activatable ratiometric near-infrared bimodal probes for early monitoring of tumor response to therapy
por: Wu, Luyan, et al.
Publicado: (2021)

Assessment of thrombin-activatable fibrinolysis inhibitor (TAFI) activation in acquired hemostatic dysfunction: a diagnostic challenge
por: Kim, Hyun Kyung
Publicado: (2010)

Large-scale preparation of active caspase-3 in E. coli by designing its thrombin-activatable precursors
por: Kang, Hyo Jin, et al.
Publicado: (2008)

Thrombin activatable fibrinolysis inhibitor as a bleeding predictor in liver transplantation: a pilot observational study
por: Nedel, Wagner Luis, et al.
Publicado: (2016)

Tuning of Peptide Cytotoxicity with Cell Penetrating Motif Activatable by Matrix Metalloproteinase-2
por: Lee, Jeonghun, et al.
Publicado: (2022)

Increased Thrombin-Activatable Fibrinolysis Inhibitor and Decreased Tissue Factor Pathway Inhibitor and Thrombomodulin Levels in Children with Hypothyroidism
por: Alioğlu, Bülent, et al.
Publicado: (2012)

Tissue-type plasminogen activator transgenic rats for evaluating inhibitors of the activated form of thrombin-activatable fibrinolysis inhibitor
por: Ito, Yusuke, et al.
Publicado: (2018)

A Genome-wide Study of Common and Rare Genetic Variants Associated with Circulating Thrombin Activatable Fibrinolysis Inhibitor
por: Stanne, Tara M., et al.
Publicado: (2018)

A ratiometric fluorescence sensor based on enzymatically activatable micellization of TPE derivatives for quantitative detection of alkaline phosphatase activity in serum
por: Lee, Jeongmoo, et al.
Publicado: (2020)

An enzyme-activatable dual-readout probe for sensitive β-galactosidase sensing and Escherichia coli analysis
por: Huang, Yifang, et al.
Publicado: (2022)

Thrombin-activatable fibrinolysis inhibitor Thr325Ile polymorphism and plasma level in breast cancer: A pilot study
por: Fawzy, Manal S., et al.
Publicado: (2015)

Dose-Response Relationship Between Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) and Stroke: A Chinese Case-Control Study
por: Dai, Huixu, et al.
Publicado: (2017)

A Case-Control Study of the Dose-Response Relationship Between Thrombin Activatable Fibrinolysis Inhibitor and Acute Myocardial Infarction
por: Zhao, Mengnan, et al.
Publicado: (2022)

The tetrapeptide core of the carrier peptide Xentry is cell-penetrating: novel activatable forms of Xentry
por: Montrose, Kristopher, et al.
Publicado: (2014)

Isolation, Co-Crystallization and Structure-Based Characterization of Anabaenopeptins as Highly Potent Inhibitors of Activated Thrombin Activatable Fibrinolysis Inhibitor (TAFIa)
por: Schreuder, Herman, et al.
Publicado: (2016)

A mutated factor X activatable by thrombin corrects bleedings in vivo in a rabbit model of antibody-induced hemophilia A
por: Abache, Toufik, et al.
Publicado: (2019)

siRNA suppression of hTERT using activatable cell-penetrating peptides in hepatoma cells
por: Li, Hua, et al.
Publicado: (2015)

Relationship Between Polymorphism of Thrombin-Activatable Fibrinolysis Inhibitor Gene +1040C/T and a Cohort of Chinese Women With Recurrent Spontaneous Abortion
por: Fang, Ping, et al.
Publicado: (2021)

Development of Radiolabeled Membrane Type-1 Matrix Metalloproteinase Activatable Cell Penetrating Peptide Imaging Probes
por: van Duijnhoven, Sander M. J., et al.
Publicado: (2015)

Near infrared-activatable biomimetic nanogels enabling deep tumor drug penetration inhibit orthotopic glioblastoma
por: Zhang, Dongya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c30vpct4ooe4pel4q6cr7qk1aj